TY  - CHAP
AU  - Johnson, Mari-Vaughn V.
AU  - Shrestha, Uttam Babu
AU  - Neergheen, Vidushi S.
AU  - Kagansky, Alexander
AU  - Pešić, Milica
AU  - Malone, John H.
PY  - 2020
UR  - https://www.sciencedirect.com/science/article/pii/B9780128195413000268
UR  - https://radar.ibiss.bg.ac.rs/handle/123456789/3844
AB  - Biological diversity sustains humanity. It is the nature of the evolutionary process for biodiversity to wax and wane over time, but biodiversity is currently declining at rates undocumented in human history and anthropogenic activities are the primary drivers of biodiversity losses. A variety of solutions have been proposed as means to protect nature and, more specifically, biodiversity. The book you hold posits an idea that may work: the commodification of nature through the lens of biomedical benefits. It remains to be proven whether our decisions and actions will follow this approach and, more so, whether we can pursue this approach in a sustainable relationship with nature, curbing the ongoing rapid species loss while maximizing medical benefits. The challenges are many, cross-cultural, and span engineering and scientific disciplines. The entire value chain iterating between biodiversity and biomedicine requires significant investments of time, money, and expertise if this endeavor is to work. Briefly, challenges include: (1) discovering and documenting species diversity; (2) cataloging traditional medicines developed from these species, including medicinal preparations (e.g., fermentation, desiccation, etc.); (3) assaying genetic and chemical diversity of natural products; (4) testing promising metabolites and other compounds for medical applicability and efficacy (and in turn developing drugs as appropriate); (5) determining why some conservation efforts succeed and others fail; (6) negotiating policies that incentivize and empower local communities to conserve the diversity in their vicinity, while also enacting policies that protect ecosystems from biopiracy and illicit harvesting and trade; and (7) strengthening and developing policy and institutional frameworks to codify and maintain working solutions. Sustainable solutions that bridge biodiversity to biomedicine may include the adoption of policies that shift paradigms around “ownership” of nature and the ecosystem services humans enjoy from diverse systems. Here we provide a context for the concept of commodifying ecosystem services as natural resources.
PB  - Cambridge (Massachusetts, United States) : Academic Press - Elsevier
T2  - Biodiversity and Biomedicine: Our Future
T1  - Biomedicine: biodiversity’s panacea? Context of commodification
DO  - 10.1016/B978-0-12-819541-3.00026-8
SP  - 525
EP  - 537
ER  - 

@inbook{
author = "Johnson, Mari-Vaughn V. and Shrestha, Uttam Babu and Neergheen, Vidushi S. and Kagansky, Alexander and Pešić, Milica and Malone, John H.",
year = "2020",
abstract = "Biological diversity sustains humanity. It is the nature of the evolutionary process for biodiversity to wax and wane over time, but biodiversity is currently declining at rates undocumented in human history and anthropogenic activities are the primary drivers of biodiversity losses. A variety of solutions have been proposed as means to protect nature and, more specifically, biodiversity. The book you hold posits an idea that may work: the commodification of nature through the lens of biomedical benefits. It remains to be proven whether our decisions and actions will follow this approach and, more so, whether we can pursue this approach in a sustainable relationship with nature, curbing the ongoing rapid species loss while maximizing medical benefits. The challenges are many, cross-cultural, and span engineering and scientific disciplines. The entire value chain iterating between biodiversity and biomedicine requires significant investments of time, money, and expertise if this endeavor is to work. Briefly, challenges include: (1) discovering and documenting species diversity; (2) cataloging traditional medicines developed from these species, including medicinal preparations (e.g., fermentation, desiccation, etc.); (3) assaying genetic and chemical diversity of natural products; (4) testing promising metabolites and other compounds for medical applicability and efficacy (and in turn developing drugs as appropriate); (5) determining why some conservation efforts succeed and others fail; (6) negotiating policies that incentivize and empower local communities to conserve the diversity in their vicinity, while also enacting policies that protect ecosystems from biopiracy and illicit harvesting and trade; and (7) strengthening and developing policy and institutional frameworks to codify and maintain working solutions. Sustainable solutions that bridge biodiversity to biomedicine may include the adoption of policies that shift paradigms around “ownership” of nature and the ecosystem services humans enjoy from diverse systems. Here we provide a context for the concept of commodifying ecosystem services as natural resources.",
publisher = "Cambridge (Massachusetts, United States) : Academic Press - Elsevier",
journal = "Biodiversity and Biomedicine: Our Future",
booktitle = "Biomedicine: biodiversity’s panacea? Context of commodification",
doi = "10.1016/B978-0-12-819541-3.00026-8",
pages = "525-537"
}

Johnson, M. V., Shrestha, U. B., Neergheen, V. S., Kagansky, A., Pešić, M.,& Malone, J. H.. (2020). Biomedicine: biodiversity’s panacea? Context of commodification. in Biodiversity and Biomedicine: Our Future
Cambridge (Massachusetts, United States) : Academic Press - Elsevier., 525-537.
https://doi.org/10.1016/B978-0-12-819541-3.00026-8

Johnson MV, Shrestha UB, Neergheen VS, Kagansky A, Pešić M, Malone JH. Biomedicine: biodiversity’s panacea? Context of commodification. in Biodiversity and Biomedicine: Our Future. 2020;:525-537.
doi:10.1016/B978-0-12-819541-3.00026-8 .

Johnson, Mari-Vaughn V., Shrestha, Uttam Babu, Neergheen, Vidushi S., Kagansky, Alexander, Pešić, Milica, Malone, John H., "Biomedicine: biodiversity’s panacea? Context of commodification" in Biodiversity and Biomedicine: Our Future (2020):525-537,
https://doi.org/10.1016/B978-0-12-819541-3.00026-8 . .